The 30-second summary
- On average, the evidence is reassuring: large 2026 datasets link GLP-1 use to lower anxiety and depression risk, not higher.
- Some women feel more anxious early on, usually from nausea, under-eating, poor sleep, or blood-sugar swings, and it tends to settle.
- Any new, persistent, or severe mood change, or any dark thoughts, is a reason to call your clinician, not to adjust the dose yourself.
The overall picture is good
Anxiety is one of the more anxious things to search about a new medication, so let us lead with what the data says. Large 2026 analyses mapping health outcomes across millions of people have linked GLP-1 use to reduced rates of anxiety, depression, and self-harm on average, not increased ones. (See GLP-1s and the brain and GLP-1s and mood.)
The likely reasons are the same threads running through this year's research: lower inflammation, steadier blood sugar, less of the constant food chatter that wears women down, and the confidence that comes with feeling more in control. (See food noise and GLP-1s and inflammation.)
Why some women feel worse at first
Averages hide individuals, and some women do feel more on edge in the early weeks. The usual, treatable culprits:
- Under-eating. Very low intake and low protein leave you shaky and irritable. (See what to eat on Ozempic.)
- Blood-sugar swings. Skipping meals on a GLP-1 can produce the jittery, anxious feeling of a low.
- Nausea and poor sleep. Both fray the nerves. (See nausea on day three and GLP-1s and sleep.)
Fix the basics and the edge often comes off.
The line that matters
There is one place to be firm rather than reassuring. If you notice any new dark thoughts, thoughts of self-harm, or a serious drop in mood, treat it as urgent: contact your prescriber or a crisis line straight away, and do not change your medication alone. This is rare, and it is exactly the kind of thing worth naming clearly.
What Steady does with this
Steady treats mood as data worth watching, not a footnote.
- Mood, fatigue, and sleep logged on a simple slider, so a shift shows up early.
- Your cycle phase read alongside, since anxiety moves with hormones for many women.
- A clear month for your clinician, so a mental-health conversation starts from your real pattern.
If you are struggling, please reach out to a professional. Steady is a companion, not a substitute for care.
Read next: GLP-1s and mood, GLP-1s and the brain, and food noise.
Sources
- Nature Medicine / WashU-VA outcome mapping of GLP-1 use, including neuropsychiatric outcomes. 2026. ScienceDaily summary
- Lincoff AM, et al. Semaglutide and inflammation (SELECT). NEJM 2023. NEJM
Medical disclaimer: Articles in the Steady research hub are educational, not medical advice. If you are in crisis, contact your local emergency number or a crisis line now. See our full medical disclaimer.